Hydromorphone Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Hydromorphone Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 11/01/2017. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-854-10
- Dosage Form
- Injection
- Presentation
- Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10)
- Initial Posting
- 11/01/2017
- Revised Date
Reason
Other